Gary Holland to Drug Implants
This is a "connection" page, showing publications Gary Holland has written about Drug Implants.
Connection Strength
0.274
-
Treatment options for cytomegalovirus retinitis: a time for reassessment. Arch Ophthalmol. 1999 Nov; 117(11):1549-50.
Score: 0.039
-
Cytomegalovirus retinitis--evolving therapies in a new era. N Engl J Med. 1999 Apr 08; 340(14):1109-10.
Score: 0.038
-
Therapeutic decisions: informed choices in a changing clinical environment. Am J Ophthalmol. 1999 Mar; 127(3):327-8.
Score: 0.037
-
Longitudinal Vision-Related Quality of Life for Patients with Noninfectious Uveitis Treated with Fluocinolone Acetonide Implant or Systemic Corticosteroid Therapy. Ophthalmology. 2017 11; 124(11):1662-1669.
Score: 0.033
-
Cytomegalovirus retinitis: are intraocular devices the answer? Br J Ophthalmol. 1995 Dec; 79(12):1066-7.
Score: 0.030
-
Outcome of Treatment of Uveitic Macular?Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year?Results. Ophthalmology. 2015 Nov; 122(11):2351-9.
Score: 0.029
-
Local therapy for cytomegalovirus retinopathy. Am J Ophthalmol. 1995 Sep; 120(3):376-85.
Score: 0.029
-
Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial. Invest Ophthalmol Vis Sci. 2012 Mar; 53(3):1169-76.
Score: 0.023
-
Outcomes associated with ganciclovir implants in patients with AIDS-related cytomegalovirus retinitis. Ophthalmology. 2006 Apr; 113(4):683.e1-8.
Score: 0.015